Today: 9 June 2026
AmpliTech’s 5G Radio Test Moves AMPG Shares
9 June 2026
2 mins read

AmpliTech’s 5G Radio Test Moves AMPG Shares

NEW YORK, June 9, 2026, 08:08 EDT

  • AmpliTech (AMPG) shares soared 26.7% to finish Monday at $6.57. The jump followed the company’s June 8 Open RAN testing update.
  • The company said its 64T64R Massive MIMO radio was the only one of its kind at the O-RAN Alliance Global PlugFest Spring 2026 event.
  • No new order in the release, so investors are still waiting to see if testing will turn into actual sales.

AmpliTech Group, Inc. traded actively ahead of the U.S. open Tuesday. The Nasdaq-listed telecom gear maker’s stock gained 26.7% Monday. Traders moved on the latest Open RAN testing update. There was no new contract news.

AmpliTech is making its case now as it aims to prove that its U.S.-built 5G radio can run in carrier networks that use gear from multiple vendors. Open RAN, or open radio access network, is a push by the industry to make the mobile network layer—the one linking devices to the core—more open and able to work across brands.

Timing is a factor here. At 08:08 a.m. EDT, Nasdaq regular trading wasn’t open yet—its session runs 9:30 a.m. to 4 p.m. ET, with pre-market between 4 a.m. and 9:30 a.m. ET. June 9 isn’t shown as a holiday on Nasdaq’s 2026 calendar; the next listed closure is Juneteenth, June 19.

AmpliTech said Monday its O-RAN CAT B 64T64R Massive MIMO radio joined the O-RAN Alliance Global PlugFest Spring 2026, held between February and May. The company said Massive MIMO, or multiple-input multiple-output, uses a large number of antennas to boost wireless capacity and coverage.

The company said 31 companies and institutions joined the event, which spanned nine labs. Its radio worked with equipment from more than one vendor in tests held with operators and tech groups including AT&T, Deutsche Telekom, Korea Telecom, LG Uplus, Orange, and Rakuten Mobile.

AmpliTech founder and CEO Fawad Maqbool said in a statement the company was the only 64T64R radio present at the PlugFest event. “Open RAN interoperability is real, not theoretical,” Maqbool said in the release. GlobeNewswire

AMPG saw active trading Monday. Finviz reported 10.25 million shares changed hands. The June 8 GlobeNewswire release showed up at 8:00 a.m., and later a Stocktwits post questioned the move in the stock.

AmpliTech is still in the early stages financially. The company posted first-quarter revenue of $5.35 million, a gain of 48.6% from the same period last year. Gross margin came in at 48.0%. Net loss narrowed by 17.3% to $1.52 million. AmpliTech finished March with $18.4 million in cash, cash equivalents and marketable securities.

AmpliTech is pushing 5G O-RAN radios and its own radio-frequency and microwave technology into the market. Radio frequency, or RF, is the range of bands in wireless communications. In May, the company said it supplied hardware for an open-source Massive MIMO AI-RAN demo with NVIDIA and Northeastern University.

Competitive pressure remains. Dell’Oro Group put Huawei, Ericsson, and Nokia at the top of the global RAN supplier ranks by 2025 revenue, with market concentration hitting its highest point in a decade. “We still expect the RAN market to be mostly flat in 2026,” said Stefan Pongratz, vice president for RAN market research at Dell’Oro. Dell Oro Group

But PlugFest’s latest update didn’t mention any new purchase orders or revenue. If carrier tests don’t become real deployments, or if bigger suppliers keep packaging radio gear inside wider network contracts, Monday’s stock jump may not last.

Next up is more a question of timing than lab results. AmpliTech has said that 2026 revenue recognition will likely lean to the second half of the year, as customer deliveries, production scheduling and order flow all point to that timing.

Stock Market Today

  • AmpliTech Shares Surge 26.7% on 5G Open RAN Testing Update
    June 9, 2026, 9:16 AM EDT. AmpliTech (AMPG) shares surged 26.7% to $6.57 following its Open RAN testing update at the O-RAN Alliance Global PlugFest Spring 2026. The company's 64T64R Massive MIMO radio, which uses multiple antennas to enhance wireless capacity, was the only one of its kind tested with equipment from major operators including AT&T and Deutsche Telekom. Despite the strong test results, no new sales orders were announced, leaving investors cautious about future revenue impact. AmpliTech reported a 48.6% increase in first-quarter revenue to $5.35 million but remains unprofitable, narrowing its net loss to $1.52 million. The firm holds $18.4 million in cash and securities. Open RAN aims to enable multi-vendor interoperability in 5G networks, a critical push in telecom infrastructure modernization.

Latest articles

GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

9 June 2026
GSK will buy Nuvalent for $10.6 billion in cash, paying a 40% premium, to boost its oncology pipeline ahead of looming HIV drug patent expiries; Nuvalent shares jumped 38.9% premarket while GSK fell 1.4%, with the deal expected to add to GSK sales and profit from 2027 but dilute earnings per share 2026-2028 if it closes in Q3, and final outcome depends on FDA approvals and regulatory clearance.
AmpliTech’s 5G Radio Test Moves AMPG Shares

AmpliTech’s 5G Radio Test Moves AMPG Shares

9 June 2026
AMPG soared 26.7% to $6.57 after AmpliTech revealed its 64T64R Massive MIMO radio was the only one of its kind at O-RAN PlugFest, showing interoperability with major carriers’ equipment, but no new orders were announced, leaving sales conversion as the key investor focus.
Cartesian Growth Ticker Change Draws Trader Attention to Factorial Energy

Cartesian Growth Ticker Change Draws Trader Attention to Factorial Energy

9 June 2026
Factorial Energy surged 16% to $13.80 in its Nasdaq debut as FAC, with premarket trading near $20.70, after replacing CGCT via SPAC merger that raised over $100 million for battery commercialization and implied a $1.3 billion equity value; former CGCT shares now trade as FAC, with founders retaining majority voting power and staged lock-up releases ahead.
Pfizer Falls in Premarket; Fresh FDA Approval Not Lifting the Stock

Pfizer Falls in Premarket; Fresh FDA Approval Not Lifting the Stock

9 June 2026
Pfizer shares fell 1.7% premarket to $25.62 as investors weighed an FDA label expansion for hemophilia drug Hympavzi—now the first subcutaneous non-factor therapy for children 6-11 with hemophilia B—against slower progress in obesity drugs, with mid-stage data for weight-loss shot berobenatide showing a 23.3% vomiting rate and no immediate growth catalyst for the $147 billion company.
Snap Shares Fall Even as Nasdaq Gains; June 16 in Focus

Snap Shares Fall Even as Nasdaq Gains; June 16 in Focus

9 June 2026
Snap Inc. shares fell 1.9% to $5.65, underperforming a rising Nasdaq and leaving the stock 46% below its 52-week high, as investors weigh weak ad revenue growth, North American user declines, and cost-cutting moves against ongoing competitive pressure from Meta and TikTok.
Cartesian Growth Ticker Change Draws Trader Attention to Factorial Energy
Previous Story

Cartesian Growth Ticker Change Draws Trader Attention to Factorial Energy

GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show
Next Story

GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

Go toTop